Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago.

Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease and mortality worldwide. Direct-acting antiviral (DAA) therapy leads to high cure rates. However, persons who inject drugs (PWID) are at risk for reinfection after cure and may require multiple DAA treatments to reach the...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Eric Tatara, Alexander Gutfraind, Nicholson T Collier, Desarae Echevarria, Scott J Cotler, Marian E Major, Jonathan Ozik, Harel Dahari, Basmattee Boodram
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Public Library of Science (PLoS) 2022-01-01
Saila:	PLoS ONE
Sarrera elektronikoa:	https://doi.org/10.1371/journal.pone.0264983
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!